Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01119118 | ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer | terminated | Phase 2 | 6 | University of Wisconsin, MadisonOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT01533753 | Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer | terminated | Phase 2 | 5 | University of Wisconsin, MadisonOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT02758132 | Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases | terminated | Phase 2 | 1 | University of HawaiiOTHER | 1 | Nov 8, 2019 | clinicaltrials |
| NCT01562522 | Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study.(EXPEDIENT) | terminated | Phase 2 | 6 | IpsenINDUSTRY | 1 | Nov 7, 2019 | clinicaltrials |
| NCT02500901 | Enzalutamide and Niraparib in the Treatment of Metastatic Castrate-Resistant Prostate Cancer (CRPC) | terminated | Phase 1 | 2 | Paul Mathew, MDOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT01253642 | Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel | terminated | Phase 2 | 11 | OHSU Knight Cancer InstituteOTHER | 1 | Oct 2, 2019 | clinicaltrials |
| NCT01374087 | Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer(ANABRAQ) | terminated | Phase 2 | 32 | IpsenINDUSTRY | 1 | Sep 18, 2019 | clinicaltrials |
| NCT00124917 | Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer | terminated | Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Sep 13, 2019 | clinicaltrials |
| NCT03011749 | Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients | terminated | N/A | 6 | Rigshospitalet, DenmarkOTHER | 1 | Sep 12, 2019 | clinicaltrials |
| NCT02710422 | Miami Membrane for Potency (MMEP) Trial(MMEP) | terminated | Phase 2 | 24 | University of MiamiOTHER | 1 | Sep 11, 2019 | clinicaltrials |
| NCT01126879 | Genistein in Treating Patients With Prostate Cancer | terminated | Phase 2 | 12 | Northwestern UniversityOTHER | 1 | Sep 10, 2019 | clinicaltrials |
| NCT01737151 | Stereotactic Body Radiation Therapy in Treating Patients With Low- and Intermediate-Risk Prostate Cancer | terminated | N/A | 19 | Virginia Commonwealth UniversityOTHER | 1 | Sep 3, 2019 | clinicaltrials |
| NCT01981109 | Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer(PREDICT) | terminated | — | 225 | DendreonINDUSTRY | 1 | Aug 28, 2019 | clinicaltrials |
| NCT00619515 | Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer | terminated | N/A | 73 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 22, 2019 | clinicaltrials |
| NCT01727154 | Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T(PRIME) | terminated | — | 139 | DendreonINDUSTRY | 1 | Aug 19, 2019 | clinicaltrials |
| NCT01420965 | Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer | terminated | Phase 2 | 7 | Augusta UniversityOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT03242265 | Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy(ANKA-PCA) | terminated | N/A | 84 | ATGen Canada IncINDUSTRY | 1 | Jul 5, 2019 | clinicaltrials |
| NCT02173522 | Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients | terminated | N/A | 4 | Shivank BhatiaOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT00798187 | Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis | terminated | — | 240 | M.D. Anderson Cancer CenterOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT01996852 | Improving Erectile Function and Quality of Life After Prostate Cancer Treatment | terminated | N/A | 34 | Case Comprehensive Cancer CenterOTHER | 1 | May 10, 2019 | clinicaltrials |
| NCT02121600 | 18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer | terminated | N/A | 5 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | May 7, 2019 | clinicaltrials |
| NCT02911922 | Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer | terminated | N/A | 1 | Weill Medical College of Cornell UniversityOTHER | 1 | Apr 29, 2019 | clinicaltrials |
| NCT02501759 | Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer | terminated | N/A | 2 | OHSU Knight Cancer InstituteOTHER | 1 | Apr 3, 2019 | clinicaltrials |
| NCT02900248 | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice(N1) | terminated | — | 23 | CureOneOTHER | 1 | Apr 2, 2019 | clinicaltrials |
| NCT00996502 | Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer | terminated | Phase 1 / Phase 2 | 4 | Columbia UniversityOTHER | 1 | Mar 27, 2019 | clinicaltrials |
| NCT01478828 | Pre-Prostatectomy Lovastatin on Prostate Cancer | terminated | N/A | 2 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 27, 2019 | clinicaltrials |
| NCT01994590 | Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) | terminated | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 19, 2019 | clinicaltrials |
| NCT01445054 | 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer | terminated | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 11, 2019 | clinicaltrials |
| NCT02584400 | Tumor Hypoxia With HX4 PET in Several Diseases(HX4 SD) | terminated | Phase 2 | 1 | Maastricht Radiation OncologyOTHER | 1 | Mar 8, 2019 | clinicaltrials |
| NCT01163084 | Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer | terminated | Phase 1 / Phase 2 | 10 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2019 | clinicaltrials |
| NCT02459912 | Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer(POTENT-C) | terminated | Phase 2 | 1 | NYU Langone HealthOTHER | 1 | Feb 6, 2019 | clinicaltrials |
| NCT03227744 | A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance | terminated | N/A | 26 | NYU Langone HealthOTHER | 1 | Feb 6, 2019 | clinicaltrials |
| NCT01741753 | BKM120+Abiraterone Acetate for Metastatic CRPC | terminated | Phase 1 | 4 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 5, 2019 | clinicaltrials |
| NCT02478125 | Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer | terminated | Phase 1 | 3 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jan 18, 2019 | clinicaltrials |
| NCT01262664 | A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT00544076 | ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer | terminated | Phase 3 | 110 | City of Hope Medical CenterOTHER | 1 | Jan 2, 2019 | clinicaltrials |
| NCT00924807 | Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer | terminated | Phase 1 / Phase 2 | 4 | Beth Israel Medical CenterOTHER | 1 | Dec 11, 2018 | clinicaltrials |
| NCT00526591 | Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer | terminated | Phase 2 | 17 | Jorge A. Garcia, MDOTHER | 1 | Dec 6, 2018 | clinicaltrials |
| NCT01703065 | Cabozantinib in Men With Castration-Resistant Prostate Cancer | terminated | Phase 2 | 9 | University of WashingtonOTHER | 1 | Dec 4, 2018 | clinicaltrials |
| NCT02560051 | Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancer | terminated | Phase 2 | 19 | The University of Texas Health Science Center, HoustonOTHER | 1 | Nov 28, 2018 | clinicaltrials |
| NCT02494713 | Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer | terminated | Phase 2 | 4 | The University of Texas Health Science Center, HoustonOTHER | 1 | Nov 27, 2018 | clinicaltrials |
| NCT00103376 | Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer | terminated | Phase 2 | 23 | Medical University of South CarolinaOTHER | 1 | Nov 5, 2018 | clinicaltrials |
| NCT00080782 | Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases | terminated | Phase 2 | 14 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00851682 | Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma | terminated | N/A | 65 | Washington University School of MedicineOTHER | 1 | Oct 31, 2018 | clinicaltrials |
| NCT00672009 | A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer | terminated | Phase 2 | 11 | Cedars-Sinai Medical CenterOTHER | 1 | Oct 24, 2018 | clinicaltrials |
| NCT02450201 | MRI With C13 Pilot Study Prostate Cancer | terminated | Early Phase 1 | 5 | University of California, San FranciscoOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT01354951 | Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer | terminated | Phase 2 | 3 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 19, 2018 | clinicaltrials |
| NCT00670046 | Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer | terminated | Phase 2 | 15 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT01795365 | Active Surveillance of 2 Groups of Patients With Localized Prostate Cancer | terminated | N/A | 60 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Sep 28, 2018 | clinicaltrials |
| NCT00953576 | Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer(KHLAD) | terminated | Phase 1 / Phase 2 | 11 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 4, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Nov 21, 2019source: clinicaltrials